Kolexia
Lepage Come Gastro-entérologie
Lepage Come
Gastro-entérologie
Hôpital François Mitterrand
Dijon, France
332 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du côlon Tumeurs colorectales Adénocarcinome Carcinomes Tumeurs du pancréas Métastase tumorale Tumeurs du foie Tumeurs neuroendocrines Tumeurs du rectum

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Aparicio Thomas
Aparicio Thomas
Hôpital Avicenne, Bobigny, France
Phelip Jean-Marc
Phelip Jean-Marc
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
Ipsen
18 collaboration(s)
Dernière en 2022
Advanced Accelerator Applications
18 collaboration(s)
Dernière en 2022
Pierre Fabre
8 collaboration(s)
Dernière en 2023
Amgen
6 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
FOxTROT2France: Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced But Resecable Colon Cancer in the Elderly of 70 Years Old or More Phase III Multicentric Open-label Randomized Controlled Trial
Essai Clinique (CHU Dijon-Bourgogne)   27 février 2024
FAMCAP: Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening, in First Degree Relatives of Patients With Colorectal Neoplasia: a Prospective Randomized Study.
Essai Clinique (Hôpital Edouard Herriot)   26 février 2024
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 février 2024
TASKIN: Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
CIRCULATE PAC: Phase III Multicentric, Open-label, Randomized Study to Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer (PRODIGE 88)
Essai Clinique (CHU Dijon-Bourgogne)   08 janvier 2024
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
European journal of endocrinology   16 décembre 2023
OPALINE: AN OBSERVATIONAL REAL-WORLD STUDY OF THE SYSTEMIC TREATMENT OF WELL-DIFFERENTIATED, UNRESECTABLE OR METASTATIC, PROGRESSIVE PANCREATIC NEUROENDOCRINE TUMOURS (PNET): A STUDY OF MORBIDITY AND MORTALITY AT 2 YEARS
Essai Clinique (Pfizer)   09 novembre 2023
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
JAMA oncology   19 octobre 2023
567P Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients: Results from the PETACC 8 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023